Page last updated: 2024-10-25

ciprofloxacin and Aortic Valve Disease 1

ciprofloxacin has been researched along with Aortic Valve Disease 1 in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Xiang, B	2
Abudupataer, M	2
Liu, G	2
Zhou, X	2
Liu, D	2
Zhu, S	2
Ming, Y	2
Yin, X	2
Yan, S	2
Sun, Y	2
Lai, H	2
Wang, C	2
Li, J	2
Zhu, K	2

Other Studies

1 other study available for ciprofloxacin and Aortic Valve Disease 1

Article	Year
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm. JCI insight, 2023, Jan-24, Volume: 8, Issue:2 Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear	2023
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm. JCI insight, 2023, Jan-24, Volume: 8, Issue:2 Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear	2023
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm. JCI insight, 2023, Jan-24, Volume: 8, Issue:2 Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear	2023
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm. JCI insight, 2023, Jan-24, Volume: 8, Issue:2 Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear	2023